| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $139.9M | +26.3% |
| Cost of Revenue | $17.8M | +70.9% |
| R&D Expense | $16.4M | -27.1% |
| SG&A Expense | $22.0M | -37.2% |
| Operating Income | $83.6M | +95.8% |
| Pre-tax Income | $87.8M | +98.9% |
| Income Tax | $19.7M | +92.7% |
| Net Income | $68.1M | +100.8% |
| EPS (Basic) | $0.95 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $150.1M | +52.0% |
| Accounts Receivable | $21.1M | -53.5% |
| Inventory | $64.2M | +63.5% |
| Current Assets | $239.0M | +28.6% |
| Total Assets | $254.4M | +30.4% |
| Current Liabilities | $54.1M | +151.5% |
| Total Liabilities | $57.5M | +131.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $94.8M | +127.8% |
| Capital Expenditures | $22K | — |
| Investing Cash Flow | -$22K | — |
| Financing Cash Flow | -$43.4M | +5.5% |
| Free Cash Flow | $94.8M | +127.8% |
| +106.5% |
| EPS (Diluted) | $0.95 | +106.5% |
| Stockholders' Equity |
| $196.9M |
| +15.7% |